ES2109832T3 - Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion - Google Patents

Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion

Info

Publication number
ES2109832T3
ES2109832T3 ES96401491T ES96401491T ES2109832T3 ES 2109832 T3 ES2109832 T3 ES 2109832T3 ES 96401491 T ES96401491 T ES 96401491T ES 96401491 T ES96401491 T ES 96401491T ES 2109832 T3 ES2109832 T3 ES 2109832T3
Authority
ES
Spain
Prior art keywords
dermatological
pharmaceutical composition
preparation
use procedure
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96401491T
Other languages
English (en)
Inventor
Jean-Francois Grollier
Josiane Allec
Isabelle Agostini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2109832(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2109832T3 publication Critical patent/ES2109832T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks

Abstract

LA PRESENTE SOLICITUD SE REFIERE A UNA COMPOSICION DERMATOLOGICA O FARMACEUTICA DE APLICACION TOPICA, QUE COMPRENDE UN ACEITE VOLATIL, UN ACEITE SILICONADO FENILADO Y AL MENOS UN AGENTE ACTIVO DERMATOLOGICO Y/O FARMACEUTICAMENTE. LA COMPOSICION OBTENIDA PRESENTA, ENTRE OTROS, PROPIEDADES DE TRANSFERENCIA Y/O DE MIGRACION MEJORADAS. LA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE ESTA COMPOSICION MEDIANTE UNA PRENSA DE EXTRUSION.
ES96401491T 1995-07-28 1996-07-05 Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion Expired - Lifetime ES2109832T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509252A FR2737118B1 (fr) 1995-07-28 1995-07-28 Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Publications (1)

Publication Number Publication Date
ES2109832T3 true ES2109832T3 (es) 1998-01-16

Family

ID=9481520

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96401491T Expired - Lifetime ES2109832T3 (es) 1995-07-28 1996-07-05 Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion

Country Status (8)

Country Link
US (1) US6136332A (es)
EP (1) EP0755675B1 (es)
JP (1) JP2965510B2 (es)
AU (1) AU679663B2 (es)
CA (1) CA2182226A1 (es)
DE (1) DE69600065T2 (es)
ES (1) ES2109832T3 (es)
FR (1) FR2737118B1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737112B1 (fr) * 1995-07-28 1997-09-05 Oreal Utilisation de l'association de deux huiles particulieres dans une composition notamment cosmetique, et composition obtenue
WO1999040063A1 (fr) * 1998-02-06 1999-08-12 Yoshitomi Pharmaceutical Industries, Ltd. Nouveaux derives de l'acide hydroxamique de type azapeptide
WO1999060167A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
EP1169480A4 (en) * 1999-04-14 2005-02-02 Musc Found For Res Dev TISSUE-SPECIFIC AND PATHOGENIC TOXIC SUBSTANCES AND RIBOZYMES
US6515029B1 (en) 1999-04-23 2003-02-04 Kimberly-Clark Worldwide, Inc. Absorbent article having a hydrophilic lotionized bodyside liner
DE20017940U1 (de) 2000-10-19 2000-12-28 Map Gmbh Atemmaske zur Zufuhr eines Atemgases zu einem Maskenanwender sowie Ableitungseinrichtung zur Ableitung von Atemgas
US6503526B1 (en) 2000-10-20 2003-01-07 Kimberly-Clark Worldwide, Inc. Absorbent articles enhancing skin barrier function
US6756520B1 (en) 2000-10-20 2004-06-29 Kimberly-Clark Worldwide, Inc. Hydrophilic compositions for use on absorbent articles to enhance skin barrier
US6749860B2 (en) 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Absorbent articles with non-aqueous compositions containing botanicals
US20020128615A1 (en) 2000-12-22 2002-09-12 Tyrrell David John Absorbent articles with non-aqueous compositions containing anionic polymers
US7771735B2 (en) 2000-12-22 2010-08-10 Kimberly-Clark Worldwide, Inc. Absorbent articles with compositions for reducing irritation response
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
DE10162593A1 (de) * 2001-12-19 2003-07-03 Menarini Ricerche Spa Stabilisierte topische Brivudin-Formulierungen
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
CA2491034A1 (en) * 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
US20040151680A1 (en) * 2003-02-05 2004-08-05 Patil Anjali Abhimanyu Cosmetic compositions containing phenyl silicones
WO2004075854A2 (en) * 2003-02-26 2004-09-10 Program For Appropriate Technology In Health Microbicidal compositions and method of use
WO2004105662A1 (en) * 2003-05-23 2004-12-09 Program For Appropriate Technology In Health Microbicidal compositions and methods of use
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
AU2004296784B2 (en) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
EP1758589A1 (en) * 2004-06-17 2007-03-07 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
JP2008502646A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム プロピオン酸クロベタゾールとカルシトリオールとの組合せ、アルコール相、および油性相を含むスプレーの形態の組成物
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
WO2005123090A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
FR2871695B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
JP5535425B2 (ja) * 2006-12-22 2014-07-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング フィラー、その製造方法、および化粧料
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20080188445A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
WO2010039679A1 (en) * 2008-09-30 2010-04-08 The Hospital For Sick Children Compositions for proliferation of cells and related methods
US8748177B2 (en) 2008-09-30 2014-06-10 The Hospital For Sick Children Compositions for proliferation of cells and related methods
GB0919650D0 (en) * 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
US20140357729A1 (en) * 2011-12-21 2014-12-04 Maruho Co., Ltd. Topical composition containing silicone base
WO2013190703A1 (en) * 2012-06-21 2013-12-27 L'oreal Cosmetic solid composition comprise a non volatile hydrocarbonated oil, waxes and a high content from non volatile phenylated silicone oil
JP2014141475A (ja) * 2012-12-27 2014-08-07 Daiichi Sankyo Co Ltd 新規美白剤
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
US20190083379A1 (en) 2017-09-18 2019-03-21 Mast Industries (Far East) Limited Gloss lip balm formulation
US20210038616A1 (en) * 2018-03-30 2021-02-11 Rohto Pharmaceutical Co., Ltd. Solid oily external composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560740B2 (en) * 1984-01-09 1987-04-16 Unilever Plc Pharmaceutical emulsion comprising an organic lactate and silicone oil
CA1272136A (en) * 1985-04-02 1990-07-31 Grish Chandra Substantive skin care compositions comprising a polydiorganosiloxane
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5444096A (en) * 1989-06-02 1995-08-22 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH05201851A (ja) * 1992-01-30 1993-08-10 Toshiba Silicone Co Ltd 化粧用洗浄剤
JP3197640B2 (ja) * 1992-11-30 2001-08-13 朝日興業株式会社 気泡発生装置
CA2107253C (en) * 1992-12-15 1998-04-21 Anthony Castrogiovanni Cosmetic compositions with improved transfer resistance
FR2701845B1 (fr) * 1993-02-23 1995-04-07 Oreal Emulsion eau-dans-huile à usage cosmétique ou pharmaceutique.
FR2702653B1 (fr) * 1993-03-16 1995-05-24 Oreal Utilisation en cosmétique ou en application topique d'une dispersion aqueuse à base d'organopolysiloxanes non volatils et d'un polymère réticulé de chlorure de méthacryloyloxyéthyl triméthylammonium .
FR2710843B1 (fr) * 1993-10-04 1995-12-01 Oreal Composition d'organopolysiloxane d'aspect gélifié, sans gélifiant, utilisable en cosmétique et dermatologie.
FR2715294B1 (fr) * 1994-01-26 1996-03-22 Oreal Composition cosmétique ou dermatologique anhydre contenant l'association d'une huile de silicone et d'une cire d'un homo- ou copolymère d'éthylène .
US5531986A (en) * 1994-07-01 1996-07-02 The Mennen Company Low residue antiperspirant solid stick composition

Also Published As

Publication number Publication date
US6136332A (en) 2000-10-24
JPH0940548A (ja) 1997-02-10
DE69600065D1 (de) 1997-10-23
DE69600065T2 (de) 1998-01-08
EP0755675A1 (fr) 1997-01-29
FR2737118B1 (fr) 1997-09-05
FR2737118A1 (fr) 1997-01-31
CA2182226A1 (fr) 1997-01-29
JP2965510B2 (ja) 1999-10-18
EP0755675B1 (fr) 1997-09-17
AU5943096A (en) 1997-02-13
AU679663B2 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
ES2109832T3 (es) Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion
BR9611802A (pt) Composições farmacêuticas
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
BR0212475A (pt) Composições farmacêuticas
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
ES2176700T3 (es) Composiciones para la piel.
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
AR004510A1 (es) Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
BR9810495A (pt) Composição farmacêutica
ES2093400T3 (es) Composiciones dentifricas.
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
BR9702603A (pt) Composição cosmética dermatológica higiênica e/ou farmacêutica composição cosmética dermatológica higiênica e/ou farmacêutica sem transferência utilização da associação entre um composto volátil e um óleo siliconado e processo para limitar diminuir e/ou eliminar a transferência
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
BR9702608A (pt) Composição cosmética dermatológica higiênica e/ou framacêutica sem transferência utilização da associação entre um composto volátil e um polímero processo para limitar diminuir e/ou empedir a transferência
BR9702604A (pt) Composição cosmética dermatológica higiênica e/ou farmacêutica composição cosmética demartológica higiênica e/ou farmacêutica sem transferência utilizando da associação entre um composto volátil e um composto pastoso e processo para limitar diminuir e/ou elimar a transferência

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 755675

Country of ref document: ES